1.An insight on genistein as potential pharmacological and therapeutic agent
Rahman Shahedur ; Islam Rezuanul ; Swaraz AM ; Ansari Anesa ; Parvez Khasru Anowar ; Paul Kumar Depak
Asian Pacific Journal of Tropical Biomedicine 2012;(z3):1924-1937
Genistein recognized as phytoestrogens is one of the most extensively studied isoflavones. It comprises of significant portion of Asian diet including Japanese and Chinese cuisine in the form of Soy food products. Evidence showed that geinstein increases osteoblasts formation as well as decreases osteoclast production. It plays an important role in immunity; such as suppression of delayed hypersensitivity and increases host resistance to B16F10 tumor by proliferating cytotoxic T and NK cells. It also decreases the activity of lipoprotein lipase which in turn inhibits lipogenesis and prevents the uptake of glucose in type 2 diabetic in rats. Geinstein play important role in reproductive system where it regulates the productive of oestrogen and progesterone. Moreover Geinstein has the ability to inhibit the tumor and cancer cell proliferation. Numerous beneficial effect of Geinstein including cancer treatment and function in immunity, obesity, diabetes and reproductivity Geinstein proves the potentiality of phytoestrogens as a source of bioactive substance.
2.Denture induced inflammatory hyperplasia – a case report.
Kumar AM ; Veena KM ; Chatra L ; Shenai P ; Rao PK ; Prabhu RV ; Kushraj T ; Shetty P.
Pacific Journal of Medical Sciences 2014;13(2):31-35
Epulis fissuratum is a benign tumor like inflammatory hyperplastic growth which occurs on the mucosa along the borders of an ill fitting full or partial removable denture. If ulcerated, it can mimic oral squamous cell carcinoma. The treatment includes surgical removal of excess fibrous tissue and remodelling or reconstructing the denture suitably, ensuring better adaptability to the ridges. This case report describes a 55 year old male patient with characteristic clinical features of denture induced inflammatory hyperplasia.
3.Prostate cancer theragnostics biomarkers: An update
Sathish Kumar AM ; Prabhakar RAJAN ; Mohammad ALKHAMEES ; Merrel HOLLEY ; Vinoth-Kumar LAKSHMANAN
Investigative and Clinical Urology 2024;65(6):527-539
Biomarkers are molecules such as proteins, genes, or other substances that may be tested to determine the stage of the tumor in a patient. The role of prostate cancer biomarkers is pivotal and the combination of prostate cancer immunotherapy with efficient biomarkers has emerged as a beneficial treatment strategy and its use has increased rapidly. The two primary objectives of this current prostate cancer early detection programs were recognizing non-symptomatic individuals with prostate cancer requiring prostatic core biopsy and identifying men with prostate cancer who might benefit from definitive medical treatment. The progress that has been made so far in the identification of the biomarkers that can be used for the classification, prediction and prognostication of prostate cancer, and as major targets for its clinical intervention has been well summarized in this review.